The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lamictal 50 mg tablets

GlaxoSmithKline (Ireland) LimitedPA1077/061/002

Main Information

Trade NameLamictal 50 mg tablets
Active SubstancesLamotrigine
Dosage FormTablet
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/061/002

Group Information

ATC CodeN03AX Other antiepileptics
N03AX09 lamotrigine


License statusAuthorised
Licence Issued05/11/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back